JAMA Ophthalmology Author Interviews

JAMA Ophthalmology Author Interviews

Interviews with authors of articles from JAMA Ophthalmology. JAMA Ophthalmology, published continuously since 1869, is an international, peer-reviewed ophthalmology and visual science journal. Covering research, science, & clinical practice in ophthalmology and vision science.

Avsnitt(127)

Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

Interview with Johanna M. Seddon, MD, ScM, author of Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

14 Feb 201311min

Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

Interview with Ronald Klein, MD, MPH, author of Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

9 Nov 20126min

The Ophthalmic Practice of the Future

The Ophthalmic Practice of the Future

Interview with Marilyn B. Mets, MD, author of The Ophthalmic Practice of the Future.

10 Sep 201211min

Improving Preterm Ophtalmologic Care in the Era of Accountable Care Organizations

Improving Preterm Ophtalmologic Care in the Era of Accountable Care Organizations

Interview with C. Jason Wang, MD, PhD, author of Improving Preterm Ophtalmologic Care in the Era of Accountable Care Organizations.

9 Juli 201212min

Relationship of Fuchs Endothelial Corneal Dystrophy Severity to Central Corneal Thickness

Relationship of Fuchs Endothelial Corneal Dystrophy Severity to Central Corneal Thickness

Interview with Jonathan H. Lass, MD, author of Relationship of Fuchs Endothelial Corneal Dystrophy Severity to Central Corneal Thickness

9 Apr 20126min

Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

Interview with Samuel G. Jacobson, MD, PhD, author of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

9 Jan 20127min

Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma

Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma

Interview with Patricia Chévez-Barrios, MD, author of Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma

14 Nov 201110min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
svd-nyhetsartiklar
rss-vetenskapsradion
det-morka-psyket
rss-spraket
rss-ufo-bortom-rimligt-tvivel-2
medicinvetarna
rss-vetenskapsradion-2
paranormalt-med-caroline-giertz
hacka-livet
sexet
rss-tidslinjen-podcast
dumforklarat
halsorevolutionen
har-vi-akt-till-mars-an
4health-med-anna-sparre
bildningspodden